Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 81007 refers to a specific laboratory test known as a urinalysis, which is designed to screen for the presence of bacteriuria, or bacteria in the urine, without utilizing culture or dipstick methods. This test is particularly significant as bacteriuria can indicate the presence of an acute or chronic urinary tract infection (UTI). The procedure begins with the collection of a urine sample, which can be obtained through various methods such as clean catch, mid-stream void, or catheterization. Once the sample is collected, it is thoroughly mixed and then diluted using fluorescent staining dyes to enhance the visibility of the components within the urine. The analysis is conducted using automated flow cytometry, a sophisticated technique that allows for the precise measurement of different cellular elements in the urine. During this process, the urine sample is passed through a sheath and illuminated by an argon laser beam. This advanced technology enables the counting and recording of various components, including red blood cells, white blood cells, epithelial cells, casts, and bacteria. The qualitative results generated from this urinalysis provide valuable information regarding bacterial concentrations, which can be instrumental in diagnosing urinary tract infections. Overall, this procedure is a critical tool in the clinical assessment of urinary health and the identification of potential infections.
© Copyright 2026 Coding Ahead. All rights reserved.
The urinalysis for bacteriuria screening, as indicated by CPT® Code 81007, is performed under specific clinical circumstances. The following conditions may warrant this laboratory test:
The procedure for conducting a urinalysis for bacteriuria screening involves several key steps that ensure accurate results. First, a urine sample is collected using one of the following methods: clean catch, mid-stream void, or catheterization. Each method is designed to minimize contamination and obtain a representative sample of the urine. Once the sample is collected, it is important to mix it thoroughly to ensure homogeneity. Next, the urine sample is diluted with fluorescent staining dyes. This step is crucial as it enhances the visibility of the cellular components within the urine, allowing for more accurate analysis. The prepared sample is then subjected to automated flow cytometry, a highly advanced technique that utilizes a laser to analyze the sample. During this process, the urine is passed through a sheath and illuminated with an argon laser beam. As the sample flows through the laser, various cellular elements, including red blood cells, white blood cells, epithelial cells, casts, and bacteria, are counted and recorded. The automated system captures the data, which is then processed to provide qualitative results. These results indicate the concentration of bacteria present in the urine, aiding healthcare providers in diagnosing urinary tract infections and determining the appropriate course of treatment.
After the urinalysis for bacteriuria screening is completed, the results are typically available within a short timeframe, allowing for prompt clinical decision-making. Depending on the findings, further evaluation or treatment may be necessary. If bacteriuria is detected, healthcare providers may consider additional diagnostic tests or initiate appropriate antibiotic therapy based on clinical guidelines. It is also essential for healthcare professionals to communicate the results to the patient and discuss any necessary follow-up actions. In cases where no bacteria are found, the results can help rule out urinary tract infections, providing reassurance to the patient. Overall, the post-procedure phase is critical for ensuring that the results are interpreted correctly and that any necessary interventions are implemented in a timely manner.
| Short Descr | URINE SCREEN FOR BACTERIA | Medium Descr | URINALYSIS BACTERIURIA SCR XCPT CULTURE/DIPSTICK | Long Descr | Urinalysis; bacteriuria screen, except by culture or dipstick | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | Yes | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1C - Lab tests - urinalysis | MUE | 1 | CCS Clinical Classification | 206 - Microscopic examination (bacterial smear, culture, toxicology) |
| QW | Clia waived test | 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. | 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | GW | Service not related to the hospice patient's terminal condition | LT | Left side (used to identify procedures performed on the left side of the body) | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider | GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit | RT | Right side (used to identify procedures performed on the right side of the body) | XS | Separate structure, a service that is distinct because it was performed on a separate organ/structure | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2001-01-01 | Changed | Code description changed. |
| 1990-01-01 | Added | First appearance in code book in 1990. |
Get instant expert-level medical coding assistance.